Cargando…
Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway
PURPOSE: Conventional chemotherapy and enucleation usually fail to cure advanced retinoblastoma. We investigated the retinoblastoma immune microenvironment and the efficacy of the combination of dinutuximab and CD16-expressing NK-92MI (NK-92MI(hCD16-GFP)) cells on retinoblastoma cells in this study....
Autores principales: | Wang, Huixue, Yang, Jie, Pan, Hui, Tai, Mei Chee, Maher, Mohamed H, Jia, Renbing, Ge, Shengfang, Lu, Linna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218403/ https://www.ncbi.nlm.nih.gov/pubmed/32440155 http://dx.doi.org/10.2147/OTT.S228532 |
Ejemplares similares
-
Human intestinal and circulating invariant natural killer T cells are cytotoxic against colorectal cancer cells via the perforin–granzyme pathway
por: Díaz‐Basabe, Angélica, et al.
Publicado: (2021) -
Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes
Publicado: (1991) -
Faster cytotoxicity with age: Increased perforin and granzyme levels in cytotoxic CD8
(+) T cells boost cancer cell elimination
por: Zöphel, Dorina, et al.
Publicado: (2022) -
Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathway
por: Althaus, Jonas, et al.
Publicado: (2023) -
The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer
por: Chuang, C-H, et al.
Publicado: (2014)